c-kit腫瘍遺伝子のプロモーター内のGに富んだ配列は,非対称なGテトラドダイナミクスを持つ平行G四重複体を形成する
Shang-Te Danny Hsu1, Peter Varnai, Anthony Bugaut
1University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, United Kingdom.
Journal of the American Chemical Society
|August 27, 2009
まとめ
グアニンに富んだDNA配列は,遺伝子プロモーターのG四重複構造を形成する. この研究は,c-kit2 G-四重複体が,類似した構造のダイナミックな集合体として存在することを明らかにし,腫瘍遺伝子の調節を理解するために重要である.
科学分野:
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
- バイオケミストリー バイオケミストリー
背景:
- グアニンに富んだDNA配列はG四重複構造を形成する.
- これらの構造は,遺伝子プロモーター領域,特にプロトオンコゲンに見られます.
- G-クアドルプレックス折り畳みは,条件に依存し,構造的に多形である.
研究 の 目的:
- c-kit2 G-quadruplexモチーフの構造とダイナミクスを調査する.
- c-kit オンコゲンプロモーターのG-クアドルプレックスの構造的振る舞いを理解するために.
- 異なる構造的サブステートとその相互変換のダイナミクスを識別する.
主な方法:
- 溶液状態の核磁共振 (NMR) スペクトロスコピー. 溶液状態の核磁共振 (NMR) スペクトロスコピー.
- NMRスペクトロスコーピによる水素-デウテリウム交換実験.
- カリウムイオンの存在下でのG四重複形成の構造分析.
主要な成果:
- c-kit2モチーフは,平行鎖のプロペラ型のG-四重複構造を形成しています.
- 溶液の中に類似した形状の集合体が存在する.
- NMRの時間スケールでゆっくりと相互変換する少なくとも2つの動的に異なるサブ状態が特定されました.
結論:
- c-kit2 G-quadruplexは,ダイナミックな構造的多形性を示しています.
- これらのダイナミクスを理解することは,遺伝子調節におけるその機能の鍵です.
- NMRスペクトロスコピーは,複雑なG-四重複構造とダイナミクスを特徴付けるのに有効です.
関連する概念動画
Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
The Eukaryotic Promoter Region
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...


